Discover more insights into Abbott Sars Cov 2 애보트 사스 코브 2

Keywords frequently search together with Abbott Sars Cov 2 애보트 사스 코브 2

Narrow sentence examples with built-in keyword filters

Abbott Sars Cov 2 sentence examples within receptor binding domain



Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard


Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England

Abbott Sars Cov 2 sentence examples within anti spike antibody



Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status


SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays


Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG



Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera



Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera



Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2



Novel RT-ddPCR Assays for determining the transcriptional profile of SARS-CoV-2



Immunological assessment of SARS-CoV-2 infection in pregnancy from diagnosis to delivery: A multicentre prospective study



Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003



Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador.



Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.



Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland



Evaluation of a new spike (S) protein based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG



Performance verification of the Abbott SARS-CoV-2 test for qualitative detection of IgG in Cali, Colombia



Specificity of SARS-CoV-2 antibody-detection assays against S and N protein among pre-COVID-19 sera from patients with protozoan and helminth parasitic infections



Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity



Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2



Results of a Population-Based Survey to Estimate the Seroprevalence of SARS-CoV-2 Specific IgG Antibodies in Kashmir, India, Seven Months after the Appearance of the First COVID-19 Case



SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020



Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicenter cross-sectional study in ten Colombian cities.



Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation



Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020



Levels of produced antibodies after vaccination with mRNA vaccine; effect of previous infection with SARS-CoV-2



Prevalence of SARS-CoV-2 Antibodies in Hemodialysis Patients in Senegal: A Multicenter Cross-Sectional Study



Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays



Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay



Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays



Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response



Specificity of SARS-CoV-2 antibody-detection assays against S and N protein among pre-COVID-19 sera from patients with protozoan and helminth parasitic infections.



Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients



SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey



Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests



Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population



Comparative assessment of SARS-CoV-2 serology in healthcare workers with Abbott Architect, Roche Elecsys and The Binding site ELISA immunoassays.



Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts



Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months



Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa



A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays


Learn more from Abbott Sars Cov 2 애보트 사스 코브 2

Abbott Sars Cov 2 애보트 사스 코브 2


Abbott Sars Cov 2 애보트 사스 코브 2
Encyclopedia 백과사전